Enhancing Multi-Label Thoracic Disease Diagnosis with Deep Ensemble-Based Uncertainty Quantification
This addresses the critical need for trustworthy AI in clinical settings by enhancing diagnostic reliability, though it is incremental as it builds on existing ensemble methods.
The paper tackled the problem of unreliable predictive confidence in deep learning models for thoracic disease diagnosis by integrating uncertainty quantification, achieving a state-of-the-art AUROC of 0.8559 and improved calibration with an ECE of 0.0728.
The utility of deep learning models, such as CheXNet, in high stakes clinical settings is fundamentally constrained by their purely deterministic nature, failing to provide reliable measures of predictive confidence. This project addresses this critical gap by integrating robust Uncertainty Quantification (UQ) into a high performance diagnostic platform for 14 common thoracic diseases on the NIH ChestX-ray14 dataset. Initial architectural development failed to stabilize performance and calibration using Monte Carlo Dropout (MCD), yielding an unacceptable Expected Calibration Error (ECE) of 0.7588. This technical failure necessitated a rigorous architectural pivot to a high diversity, 9-member Deep Ensemble (DE). This resulting DE successfully stabilized performance and delivered superior reliability, achieving a State-of-the-Art (SOTA) average Area Under the Receiver Operating Characteristic Curve (AUROC) of 0.8559 and an average F1 Score of 0.3857. Crucially, the DE demonstrated superior calibration (Mean ECE of 0.0728 and Negative Log-Likelihood (NLL) of 0.1916) and enabled the reliable decomposition of total uncertainty into its Aleatoric (irreducible data noise) and Epistemic (reducible model knowledge) components, with a mean Epistemic Uncertainty (EU) of 0.0240. These results establish the Deep Ensemble as a trustworthy and explainable platform, transforming the model from a probabilistic tool into a reliable clinical decision support system.